|
|
|
Volumn 16, Issue 1, 1998, Pages 23-29
|
|
New chemotherapy regimens for advanced bladder cancer
a
a
|
|
Author keywords
Therapy; Transitional cell cancer; Urothelial cancer
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CALCITRIOL;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
FOLIC ACID ANTAGONIST;
GALLIUM NITRATE;
GAMMA INTERFERON;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
METHOTREXATE;
PACLITAXEL;
PIRITREXIM;
TAXANE DERIVATIVE;
TRIMETREXATE;
VINBLASTINE;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLADDER CANCER;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG POTENTIATION;
HUMAN;
HYPOCALCEMIA;
NEPHROTOXICITY;
NEUROPATHY;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
VOMITING;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DEOXYCYTIDINE;
DOXORUBICIN;
FOLIC ACID ANTAGONISTS;
GALLIUM;
HUMANS;
IFOSFAMIDE;
METHOTREXATE;
URINARY BLADDER NEOPLASMS;
VINBLASTINE;
|
|
EID: 0031885981
PISSN: 10810943
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (66)
|
